Cargando…

The underrecognized prothrombotic vascular disease of COVID‐19

Detalles Bibliográficos
Autores principales:	Cohoon, Kevin P., Mahé, Guillaume, Spyropoulos, Alex C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323147/ https://www.ncbi.nlm.nih.gov/pubmed/32685906 http://dx.doi.org/10.1002/rth2.12396

Ejemplares similares

Emergence of institutional antithrombotic protocols for coronavirus 2019
por: Cohoon, Kevin P., et al.
Publicado: (2020)

Vascular thromboembolic events following COVID‐19 hospital discharge: Incidence and risk factors
por: Spyropoulos, Alex C., et al.
Publicado: (2021)

Isolated Long White Eyelash: An Underrecognized Trichologic Finding
por: Bernabó, Jean-Luc, et al.
Publicado: (2015)

Mosquito Net: An Underrecognized Protection Measure against Snakebites
por: Mallik, Subhendu, et al.
Publicado: (2017)

Genital lichen planus: Adding to the review of an “underrecognized entity”
por: Sonthalia, Sidharth, et al.
Publicado: (2022)

Prothrombotic state induced by COVID-19 infection as trigger for stroke in young patients: A dangerous association.
por: Cavallieri, Francesco, et al.
Publicado: (2020)

Intrapulmonary lymph node: a common and underrecognized tomography finding
por: Hochhegger, Bruno, et al.
Publicado: (2013)

An underrecognized barrier to the dermatology residency match: Lack of a home program
por: Villa, Natalie M., et al.
Publicado: (2021)

Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study
por: Hardy, Michaël, et al.
Publicado: (2021)

“ISTH guidelines for antithrombotic treatment in COVID‐19”: Reply
por: Schulman, Sam, et al.
Publicado: (2022)

Discontinuation of vascular therapeutics during the COVID-19 pandemic first wave in France
por: Lanéelle, D., et al.
Publicado: (2021)

Extracardiac Prothrombotic Effects of COVID-19
por: Kankaria, Rohan, et al.
Publicado: (2022)

Extracardiac Prothrombotic Effects of COVID-19
por: Kankaria, Rohan, et al.
Publicado: (2023)

Mechanisms and management of prothrombotic state in COVID-19 disease
por: Acherjee, Trishna, et al.
Publicado: (2021)

Prothrombotic phenotype in COVID-19 severe patients
por: Helms, Julie, et al.
Publicado: (2020)

Prothrombotic State in COVID-19: Myth or Reality?
por: Bauer, Philippe R.
Publicado: (2021)

Prothrombotic Phenotype in COVID-19: Focus on Platelets
por: Barale, Cristina, et al.
Publicado: (2021)

Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19
por: Zuo, Yu, et al.
Publicado: (2020)

Glycogenic Hepatopathy in Type 1 Diabetes: An Underrecognized Condition
por: Imtiaz, Komal Eram, et al.
Publicado: (2013)

Prothrombotic changes in patients with COVID‐19 are associated with disease severity and mortality
por: von Meijenfeldt, Fien A., et al.
Publicado: (2020)

Prothrombotic immune thrombocytopenia after COVID-19 vaccination
por: Tiede, Andreas, et al.
Publicado: (2021)

Sustained prothrombotic changes in convalescent patients with COVID-19
por: von Meijenfeldt, Fien A, et al.
Publicado: (2021)

Editorial: Thrombotic Disorders, Prothrombotic Abnormalities and COVID-19
por: Di Micco, Pierpaolo, et al.
Publicado: (2021)

Prothrombotic status in COVID‑19 with diabetes mellitus (Review)
por: Mitroi, Roxana Madalina, et al.
Publicado: (2023)

The Appearance of an Underrecognized Congenital Heart Disease in a Patient With COVID-19 Pneumonia
por: Lakhdar, Sofia, et al.
Publicado: (2021)

Altered Circadian Rhythm in COVID-19 Times-Underrecognized and Undertreated
por: Ish, Pranav, et al.
Publicado: (2022)

On barring the vascular gateway against severe COVID-19 disease
por: Perdrizet, George, et al.
Publicado: (2020)

Facklamia Species as an Underrecognized Pathogen
por: Rahmati, Elham, et al.
Publicado: (2017)

Double-stranded DNA induces a prothrombotic phenotype in the vascular endothelium
por: Gaitzsch, Erik, et al.
Publicado: (2017)

Inflammatory response in relation to COVID-19 and other prothrombotic phenotypes()
por: Páramo, José A.
Publicado: (2022)

Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection
por: Lopez-Castaneda, Sandra, et al.
Publicado: (2021)

Thrombomodulin Resistance May be Involved in the Prothrombotic State of COVID-19
por: Montaño, Adrián, et al.
Publicado: (2022)

Statins and other drugs: Facing COVID-19 as a vascular disease
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Impact of COVID-19 on the vascular interventionist
por: Mousa, Albeir Y, et al.
Publicado: (2020)

The impact of COVID-19 on vascular training
por: Mousa, Albeir Y., et al.
Publicado: (2020)

Underrecognized comorbidities of chronic obstructive pulmonary disease
por: Miłkowska-Dymanowska, Joanna, et al.
Publicado: (2015)

Obstructive fibrinous tracheal pseudomembrane following tracheal stent placement: An underrecognized entity
por: Sahu, Satya Ranjan, et al.
Publicado: (2020)

Keratotic papules on the thigh: underrecognized skin manifestations of dermatomyositis or Wong-type dermatomyositis?()
por: Yamamoto, Miyuki, et al.
Publicado: (2023)

Intracranial hemorrhage related to brain vascular disease and COVID-19 containment: Where are the patients?
por: Bernat, A.-L., et al.
Publicado: (2020)

Idiopathic aortitis: an underrecognized vasculitis
por: Pipitone, Nicolò, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_dinbrnvuc9on2le2r4hokufrrm